Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin and Nitroglycerin in Liver Resection
NCT02993640Phase 1Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Sep 2016
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, open-label trial of vasopressin and nitroglycerin in Portal Hypertension (PH), sponsored by Sahlgrenska University Hospital. Primary endpoints: Portal venous flow after vasopressin and nitroglycerine infusion at 25 months, Hepatic venous flow after vasopressin and nitroglycerine infusion at 25 months and 1 more. Started Sep 2016; status: completed.
02
Drugs
vasopressinnitroglycerin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT02993640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02993640.